ARDD 2026
Aging Research & Drug Discovery
October 1–3, 2026
David Rubenstein Treehouse, Harvard University, Boston
Aging biology, drug discovery, AI, biotechnology, and translation.
Forums, workshops, and tracks
- Thu, Oct 1
Main track Canopy Hall, 3/F
Opening remarks and XPRIZE Healthspan overview · Policy & regulatory address; ARPA-H PROSPR · Clinical trials of therapeutics and regulatory mandates · Clinical trials in diseases of aging · AI & clinical trials in healthspan · Healthspan in leading industries · Aging research and pharma R&D productivity · Clinical healthspan trials and practiceXPRIZE Healthspan: Meet the Finalists Workshop Cedar Grove, 2/F, 9:20–11:30
Multimodal & clinical approach teams · Drug & biologics teams- Fri, Oct 2
Main track Canopy Hall, 3/F
Reimagining drug discovery through the lens of aging biology · Pharma chief executive panel · Longevity therapeutics as an industry · Aging clocks and GLP-1/GIP agonists · New technology partnering & licensing · Diseases as a pathway to longevity therapeutics · Early-stage and growth-stage investor panels · Epigenetic and biomarker insightsAI in Drug Discovery Forum Cedar Grove, 2/F, all day
AI & computational design · Large-scale datasets · Neurodegeneration · Systems immunology- Sat, Oct 3
Main track Canopy Hall, 3/F
Keynotes · Search & evaluation strategies for longevity therapeutics · Metabolic health and longevity · Semaglutide and healthspan · Aging research in pharma · Therapeutic assets & licensing, late and early stage · AMPK network activation · Company talks · Closing keynote and closing remarksPet and Animal Longevity Forum Cedar Grove, 2/F, morning
Canine aging · Commercializing pet longevityVirtual Cell in Time Forum Cedar Grove, 2/F, afternoon
Virtual biology models · World models · Single-cell approaches
Organized by ARDD organizing committee